DRA. MÓNICA ALICIA SIERRA DEL RIO

- Prophylactic intrathecal chemotherapy in primary CNS lymphoma.

Sierra Del Rio M, Ricard D, Houillier C, Navarro S, Gonzalez-Aguilar A, Idbaih A, Kaloshi G, Elhallani S, Omuro A, Choquet S, Soussain C, Hoang-Xuan K.

J Neurooncol. 2012 Jan;106(1):143-6.

 

-Primary CNS lymphoma in patients younger than 60: can whole-brain radiotherapy be deferred?

Omuro A, Taillandier L, Chinot O, Sierra Del Rio M, Carnin C, Barrie M, Soussain C, Tanguy ML, Choquet S, Leblond V, Hoang-Xuan K; ANOCEF Group (French Neuro-Oncology Association). J Neurooncol. 2011 Aug;104(1):323-30

 

 

- Platine and cytarabine-based salvage treatment for primary central nervous system lymphoma.

Sierra del Rio M, Choquet S, Hoang-Xuan K, Glaisner S, Fourme E, Janvier M, Soussain C.

J Neurooncol. 2011 Nov;105(2):409-14.

 

 

-Up-front temozolomide in elderly patients with anaplastic oligodendroglioma and oligoastrocytoma.

Ducray F, Sierra Del Rio M, Carpentier C, Psimaras D, Idbaih A, Dehais C, Kaloshi G, Mokhtari K, Taillibert S, Laigle-Donadey, Omuro A, Sanson M, Delattre JY, Hoang-Xuan K.

J Neurooncol. 2011 Feb;101(3):457-62

 

 

-Nitrosourea-based chemotherapy for low grade gliomas failing initial treatment

with temozolomide.

Kaloshi G, Sierra Del Rio M, Ducray F, Psimaras D, Idbaih A, Laigle-Donadey F,

Taillibert S, Houillier C, Dehais C, Omuro A, Sanson M, Delattre JY, Hoang-Xuan K.

J Neurooncol. 2010 Dec;100(3):439-41

 

-Primary CNS Lymphoma in immunocompetent patients

Sierra del Rio M, Rousseau A, Soussain C, Ricard D, Hoang-Xuan K.

Oncologist 2009 May;14(5):526-39

 

 

-Bevacizumab and irinotecan for recurrent oligodendroglial tumors.

Taillibert S, Vincent LA, Granger B, Marie Y, Carpentier C, Guillevin R, Bellanger A, Mokhtari K, Rousseau A, Psimaras D, Dehais C, Sierra del Rio M, Meng Y, Laigle-Donadey F, Hoang-Xuan K, Sanson M, Delattre JY.

Neurology. 2009 May 5;72(18):1601-6

 

-Therapeutic application of noncytotoxic molecular targeted therapy in gliomas: growth factor receptors and angiogenesis inhibitors.

Idbaih A, Ducray F, Sierra Del Rio M, Hoang-Xuan K, Delattre JY

Oncologist. 2008 Sep;13(9):978-92

 

-Treatment of primary central nervous system lymphoma in the immunocompetent patient

Sierra Del Rio M, Benouaich-Amiel A, Psimaras D, Dehais C, Hoang-Xuan K.

Rev Neurol (Paris). 2008 Jun-Jul;164(6-7):569-74

 

 

Revistas Medicas Nacionales:

 

-Primary central nervous system lymphoma (Principes de traitement des lymphomas primitives du système nerveux central chez l’immunocompétent)

Sierra del Rio M, Psimaras D, Dehais C, Kaloshi G, Hoang-Xuan K.

Oncologie. 2009 Jan ; 11(2) 78-82.